Cinacalcet is associated with decreased serum FGF-23 and improved phosphorous homeostasis in patients with tumor-induced osteomalacia.

被引:0
|
作者
Geller, JL
Cutler, C
Kelly, MH
Adams, JS
Collins, MT
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Cedars Sinai Med Ctr, Div Endocrinol,Burns & Allen Res Inst, Los Angeles, CA USA
[2] NIDCR, Craniofacial & Skeletal Dis Branch, NIH, DHHS, Bethesda, MD USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S177 / S177
页数:1
相关论文
共 47 条
  • [31] The utility of SRS/SRPET and systemic FGF23 venous sampling for tumor localization in 20 consecutive tumor-induced osteomalacia cases
    Koga, Minae
    Kato, Hajime
    Ito, Nobuaki
    Kinoshita, Yuka
    Fukumoto, Seiji
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2019, 34 : 185 - 185
  • [32] Tumor-associated FGF-23 induced hypophosphatemic rickets in an eight year old boy
    Marie-Anne, Burckhardt
    Alexandra, Schifferli
    Andreas, Krieg
    Daniel, Baumhoer
    Gabor, Szinnai
    Christoph, Rudin
    [J]. SWISS MEDICAL WEEKLY, 2013, 143 : 29S - 29S
  • [33] Tumor-Associated FGF-23 Induced Hypophosphatemic Rickets in an Eight Year Old Boy
    Burckhardt, M. -A.
    Schifferli, A.
    Krieg, A.
    Baumhoer, D.
    Szinnai, G.
    Rudin, C.
    [J]. SWISS MEDICAL WEEKLY, 2012, 142 : 3S - 3S
  • [34] Ectopic expression of Klotho in fibroblast growth factor 23 (FGF23)-producing tumors that cause tumor-induced rickets/osteomalacia (TIO)
    Kinoshita, Yuka
    Takashi, Yuichi
    Ito, Nobuaki
    Ikegawa, Shiro
    Mano, Hiroyuki
    Ushiku, Tetsuo
    Fukayama, Masashi
    Nangaku, Masaomi
    Fukumoto, Seiji
    [J]. BONE REPORTS, 2019, 10
  • [35] Tumor-induced osteomalacia associated with a maxillofacial tumor producing fibroblast growth factor 23: report of a case and review of the literature
    Mori, Yoshiyuki
    Ogasawara, Toru
    Motoi, Toru
    Shimizu, Yuichiro
    Chikazu, Daichi
    Tamura, Kazumi
    Fukumoto, Seiji
    Takato, Tsuyoshi
    [J]. ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 2010, 109 (03): : E57 - E63
  • [36] Burosumab Improved Serum Phosphorus, Osteomalacia, Mobility, and Fatigue in the 48-Week, Phase 2 Study in Adults with Tumor-induced Osteomalacia Syndrome
    De Beur, Suzanne Jan
    Miller, Paul D.
    Weber, Thomas J.
    Peacock, Munro
    Insogna, Karl L.
    Kumar, Rajiv
    Rauch, Frank
    Luca, Diana
    Theodore-Oklota, Christina
    Lampl, Kathy
    Martin, Javier San
    Carpenter, Thomas O.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 : 50 - 50
  • [37] Treatment and outcomes of tumor-induced osteomalacia associated with phosphaturic mesenchymal tumors: retrospective review of 12 patients
    Zuo, Qing-yao
    Wang, Hong
    Li, Wei
    Niu, Xiao-hui
    Huang, Yan-hong
    Chen, Jia
    You, Yu-hua
    Liu, Bao-yue
    Cui, Ai-min
    Deng, Wei
    [J]. BMC MUSCULOSKELETAL DISORDERS, 2017, 18
  • [38] Treatment and outcomes of tumor-induced osteomalacia associated with phosphaturic mesenchymal tumors: retrospective review of 12 patients
    Qing-yao Zuo
    Hong Wang
    Wei Li
    Xiao-hui Niu
    Yan-hong Huang
    Jia Chen
    Yu-hua You
    Bao-yue Liu
    Ai-min Cui
    Wei Deng
    [J]. BMC Musculoskeletal Disorders, 18
  • [39] Low Levels of Serum Sclerostin in Adult Patients With Tumor-Induced Osteomalacia Compared With X-linked Hypophosphatemia
    Ni, Xiaolin
    Zhang, Qi
    Li, Xiang
    Pang, Qianqian
    Gong, Yiyi
    Wang, Ou
    Li, Mei
    Xing, Xiaoping
    Jiang, Yan
    Xia, Weibo
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (01): : E361 - E371
  • [40] Clinical characteristics and surgical outcomes of vertebral lesions associated with tumor-induced osteomalacia: report of 16 patients and review of the literature
    Pang, Qianqian
    Zhou, Ruotong
    Ni, Xiaolin
    Liu, Yong
    Jin, Jin
    Wu, Huanwen
    Huo, Li
    Yu, Wei
    Chi, Yue
    Li, Xiang
    Wang, Ou
    Li, Mei
    Xing, Xiaoping
    Jiang, Yan
    Jiajue, Ruizhi
    Xia, Weibo
    [J]. OSTEOPOROSIS INTERNATIONAL, 2024,